ADA: Once-Weekly Icodec Superior for Reduction in HbA1c

WEDNESDAY, June 28, 2023 -- For patients with insulin-naive type 2 diabetes, once-weekly icodec is superior for reduction in hemoglobin A1c (HbA1c), according to a study published online June 24 in the Journal of the American Medical Association to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news